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In 1988, we published a novel clinical entity as a
case report: neurogenic claudication ensuing as a
consequence of pelvic vein occlusion. Distended and
tortuous veins in the spinal canal that arose from the
collateral circulation was shown by means of com-
puted tomography (CT) and digital venography
scans obtained from a patient with pelvic venous
obstruction and neurogenic claudication. We
hypothesized that these veins would swell during leg
exertion and thus provoke symptoms of a narrow
spinal canal.1 Our interest in this clinical syndrome
was raised again when it became evident that chron-
ic postthrombotic pelvic venous obstructions
(CPPVO) can be eliminated with the placement of
endoluminal stents.2 To select candidates for such
intervention, we examined 42 patients with CPPVO
for the presence of venous claudication, neurogenic
claudication, or both and attempted stenting in a
series of 14 patients with suitable anatomy.
PATIENTS AND METHODS
The diagnosis of CPPVO was made in 42
patients. The demographic data are given in Table I.
A targeted history was taken to unmask eventual
symptoms considered typical and specific of
CPPVO3: venous claudication (provoked by conges-
tion of muscles resulting from insufficient drainage)
and neurogenic claudication (caused by occupation
of space in the spinal canal by distended veins that
arise from the collateral circulation). The features of
the clinical syndromes are detailed in Table II. The
morphology of the obstruction and collateral path-
way was studied by means of subtraction venography
and duplex scanning. CT or magnetic resonance
imaging (MRI) of the lumbar spine, subtraction
venography of the lumbovertebral region with
oblique projections, or both were performed in
patients in whom neurogenic claudication was sus-
pected. A venous origin of neurogenic claudication
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was assumed when dilated veins were identified by
means of MRI, contrast enhanced CT, or subtrac-
tion venography scans, or when a native CT scan did
not reveal another reason for the symptoms. Typical
images of spinal MRI and digital venography are
shown in Figs 1 and 2.
Stenting was considered clinically suitable when
the patient had at least one of the typical symptoms
and technically feasible when the left external iliac
vein (EIV) was patent enough to allow the insertion
of a probing catheter. Nine patients had occlusions
of the common iliac vein (CIV), and five had tight
stenoses.
In addition, the EIV was occluded in two
patients, severely stenosed (less than 4 mm lumen
diameter) in five patients, and affected to a lesser
degree in the remaining seven patients. The nam-
ing of the veins and the measuring of the length of
the segments was felt to be inexact, because the
internal iliac vein (IIV) was not opacified in most
cases and measuring catheters were not used. The
stenoses and/or occlusions were easily negotiated
with a gel-coated guide wire in 10 cases. In two
cases, a 1.5 mm J-guide was forced through the
occlusion with the help of a straight probing
catheter. In two cases, the long occlusions involv-
ing the EIV could not be passed. A Wallstent with
a diameter of 12 to 16 mm and a length of 35 to
55 mm was placed from below, with its cranial end
exactly at the caval junction. A second stent was
placed distally in one case. The stents were expand-
ed fully with balloon catheters inserted from below.
Vein segments between the distal end of the stent
and the introducer sheath were dilated when the
vessel diameter was less than 10 mm. In five cases,
balloon catheters were also introduced from above
via the transbrachial route. This approach prevent-
ed eventual slipping of the stent into the caval vein,
allowed the use of the kissing balloon technique,
and permitted dilatation of the EIV down to the
femoral junction.
Anticoagulant treatment included dalteparin (200
IU/kg body weight, once daily) for 1 week and phen-
procoumon (target international normalized ratio,
2.4). At follow-up, five patients were still undergoing
anticoagulant treatment. It had been stopped in the
other six patients five to 12 months after stenting and
five to 26 months before follow-up.
Follow-up examinations with duplex scanning
(with color coding and power mode) and visual ana-
log scales to assess the symptoms were done in all 
11 patients who had a patent stent 1 week after
deployment.
RESULTS
Symptoms typical of CPPVO were ascertained in
30 of 42 patients (Table III): venous claudication in
15 patients, neurogenic claudication in four patients,
and both symptoms in 11 patients. Twelve patients
had no symptoms related to their CPPVO. The
placement of an endoluminal stent was deemed to be
possibly technically feasible in 25 patients (60%) by
means of morphologic work-up. Of these patients, 17
(68%) also had the typical symptoms and were there-
fore judged clinically suitable. Five anatomically and
clinically suitable patients declined stenting, and two
patients with suitable anatomy were stented despite a
lack of typical symptoms. Stenting was relatively easy
to perform and primarily successful in 12 of 14
attempts. The procedure failed in the two patients
with long occlusions involving the EIV. Deployment
of the stent and balloon dilatation caused some pain
in most patients and required the administration of
intravenous morphine in three cases. No untoward
events were observed. Reocclusion occurred in one
patient within the first week, despite correct anticoag-
Fig 1. Magnetic resonance imaging scans of a patient
with chronic postthrombotic pelvic venous obstruction.
Parasagittal magnetic resonance images of the lumbover-
tebral region were obtained from a patient who experi-
enced iliacofemoral thrombosis 11 years earlier and suf-
fered from symptoms of a narrow spinal canal since then.
Dilated and slightly tortuous veins are present in the spinal
canal. Stenting of the completely occluded pelvic axis was
not feasible.
Fig 2. Venographic study in a patient with chronic postthrombotic pelvic venous obstruction.
Digital venography was performed in a patient who experienced left-sided pelvic and leg vein
thrombosis 18 years earlier. She had lower back pain and occasional sciatica since then. Typical
symptoms of a narrow spinal canal appeared regularly after the patient started mountain walk-
ing five years earlier. Contrast material was injected through a catheter placed in the left exter-
nal iliac vein. The upper images display an oblique projection. The mask image (right) shows
contrast in the external iliac vein and complete occlusion of the common iliac vein at its under-
crossing of the right common iliac artery. The left panel displays a later subtracted image by
which dilated veins in the spinal canal that arise from the collateral circulation are shown. The
lower images are taken from the anterior-posterior projection. The right scan shows the net-
work of the collateral circulation. The pair of distended veins in the spinal canal takes part in
the drainage pathway. The left image shows the situation immediately after the reopening of
the common iliac vein by means of a Wallstent. The collateral circulation has disappeared. The
patient was free of symptoms immediately.
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Table I. Demographic data of patients with chronic postthrombotic pelvic venous obstruction
Patients 39 women, 3 men
Mean age: 48.8 years (range, 22 to 75)
Mean time elapsed since acute occlusion: 18.2 years (range, 1.7 to 46)
Localization 38 left, 1 right, 3 bilateral pelvic veins
Concomitant postthrombotic syndrome of leg 23 patients (54%)
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ulation therapy. This patient had the shortest history
of CPPVO (20 months).
At follow-up, all stents were revealed to be patent
by means of duplex scanning. There were no mor-
phologic or functional signs of restenosis in any case.
The anatomic results are summarized in Table IV.
Major improvement of symptoms was achieved in
nine patients. One patient with neurogenic claudica-
tion and another with venous claudication reported
complete relief. The two patients whose pelvic veins
were stented despite a lack of typical symptoms had
almost no benefit. The results of symptom evaluation
with visual analog scales are shown in Fig 3.
DISCUSSION
The presence of a venous spur as the underlying
pathology of pelvic vein thrombosis has been
described by May and Thuner4 and was later termed
“iliac vein compression syndrome” by Cockett et al.5
The left CIV is compressed against the vertebral col-
umn by the crossing right iliac artery. As a conse-
quence of compression and perpetual pulsation, mor-
phologic changes develop and narrow the lumen.
Acute thrombosis can occur, involving the whole leg
in every other patient. Malformations of the iliocaval
system may also lead to pelvic vein obstruction and
the same late sequels.6
CPPVO causes typical clinical symptoms in two
thirds of patients, according to this series. Venous
claudication is a well-known symptom.7,8 The syn-
drome of a narrow spinal canal caused by dilated veins
that arise from the collateral circulation was described
10 years ago,1 but is not recognized as a typical symp-
tom yet. However, the pathophysiology of both clin-
ical syndromes seems conspicuous. During strenuous
physical exertion, blood flow to the legs increases and
so does venous return. Pelvic venous obstruction
impedes rapid drainage and causes painful congestion
of the muscles. In addition, the greatly augmented
blood volume leads to distension of the collaterals. If
collateral veins extend through the spinal canal, they
occupy space and compress nerves. The typical symp-
toms of a narrow spinal canal ensue.
In contrast to what happens when cord or root
compression is caused by osteoarthrosis or discoidal
herniation, the symptoms are not relieved with
Table IV. Technical and clinical results of stenting of chronic postthrombotic pelvic venous obstruction
Number of patients
Stenting attempted 14
Stents patent after 1 week (2 primary failures, 1 early reocclusion) 11 (79%)
Stents patent after a mean of 15 months (range, 1 to 43) 11 (79%)
Table II. Symptoms of chronic postthrombotic pelvic venous obstruction induced by physical exertion
Venous claudication Neurogenic claudication caused by distended veins in the spinal canal
Quality of pain Sensation of bursting, cramping Radiating weakness, numbness
Localization Thigh or whole affected leg Lower back, buttocks, and both legs
Beginning Slow and late Late, but sudden
Relief Slow; accelerated by leg elevation Very slow; leg elevation and spinal movements not helpful
Table III. Symptoms of patients with chronic postthrombotic pelvic venous obstruction
Patients %
Number of patients studied 42 100
Complaints at presentation
Varicose disease 16 38
Symptoms of CVI 16 38
Typical symptoms of CPPVO 10 24
Typical symptoms of CPPVO unmasked by means of specific inquiry 20 47
Total number of patients with typical symptoms of CPPVO 30 71
CVI, Chronic venous insufficiency; CPPVO, chronic postthrombotic pelvic venous obstruction.
JOURNAL OF VASCULAR SURGERY
488 Blättler and Blättler March 1999
movements of the vertebral column and they last
quite a long time. Leg elevation alleviates the burst-
ing sensation of venous claudication, but not the
symptoms of the narrow spinal canal. In the present
study, patients with CPPVO were not systematically
examined for the presence of spinal collaterals.
Therefore, conclusions on the prevalence, specificity,
or sensitivity of the symptoms cannot be drawn.
Nevertheless, consideration of the clinical syndrome
will lead clinicians to take a targeted history that may
have therapeutic consequences. According to the
experience obtained from this small series, symp-
toms regarded as typical of CPPVO can be relieved
with the straightforward placement of an endove-
nous stent.
The stenting procedure itself requires some dis-
cussion. First, it is surprising that venous occlusions of
such an old age could be overcome. We believe that
this is a specific feature of May-Thuner’s syndrome.
Small channels have been described within the origi-
nal lumen and the wall of the occluded CIV.9 The
thin gel-coated guide wire may have found its way
through such channels. More distal occlusions did not
allow the passage of a catheter. Second, it is notewor-
thy that the stents did not thrombose more frequent-
ly. We believe that this has to do with both the nature
of the occlusion (which is more fibrous than throm-
botic) and its age. Proneness to rethrombosis may
result from thrombin that is contained within the fib-
rin thrombus10 and liberated during dilatation.11 For
the reasons cited, this may not be the case in chronic
May-Thuner’s syndrome. Third, it is interesting to see
that neither restenosis nor late thrombosis occurred,
although anticoagulant treatment had been stopped
in half of the patients many months before their fol-
low-up examination. At the moment, we can only
acknowledge the phenomenon.
In summary, this report intends to make clini-
cians aware of the existence of typical symptoms in
patients with CPPVO and that these symptoms may
be relieved with the deployment of an endovenous
stent. Stenting of the CIV seems easier to perform
and to have a better patency rate than expected.
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Fig 3. Satisfaction of patients with chronic postthrom-
botic pelvic venous obstruction treated with endoluminal
stents. Ten (of 11) patients with patent stents at follow-up
were asked to rate the symptoms they still had in compar-
ison with what they felt before placement of the stent and
to state whether they would undergo the procedure again.
Bidirectional visual analog scales were used. The markings
of patients with typical symptoms before stenting are
shown with open symbols; the markings of patients lack-
ing such typical symptoms are shown with closed symbols.
